Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Martinsen (Bergen, Norway), T. Eagan (Bergen, Norway), E. Leiten (Bergen, Norway), I. Haaland (Bergen, Norway), G. Husebø (Bergen, Norway), W. Sanseverino (Barcelona, Spain), A. Paytuvi-Gallart (Barcelona, Spain), R. Nielsen (Bergen, Norway). A study of the airway mycobiome in COPD patients and controls. 1601

Member's Comments

No comment yet.

Related content which might interest you: The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Characterization and effects of bronchial colonization and inflammation in stable COPD patients. PAC-COPD study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Systemic and airways inflammation in healthy subjects and COPD patients of different ages Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 A study to define microbiome subtypes in the adult asthmatic airway Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006 A study to define the microbiome of the asthmatic airway. Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003 The effect of exacerbations on the airway microbiota in children with non-CF bronchiectasis Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 A high-risk airway mycobiome characterises frequent COPD exacerbators Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients Source: Eur Respir J 2007; 30: Suppl. 51, 177s Year: 2007 Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD Source: Eur Respir J, 57 (3) 2002050; 10.1183/13993003.02050-2020 Year: 2021 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 Systemic effects of bronchial colonization in early COPD patients enrolled in the PAC-COPD cohort Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Baseline inflammation in the lower airways of allergic rhinitic subjects compared to normal subjects Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001 Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008